The Net Margin of Lineage Cell Therapeutics Inc (LCTX) is -195.90%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2024-12-31 | -195.90% |
2023-12-31 | -240.20% |
2022-12-31 | -178.71% |
2021-12-31 | -991.24% |
2020-12-31 | -1128.42% |
2019-12-31 | -332.67% |
2018-12-31 | -921.64% |
2017-12-31 | -577.46% |
2016-12-31 | 567.06% |
2015-12-31 | -667.47% |